The Effect of Excipients on the Permeability of BCS Class III Compounds and Implications for Biowaivers

PURPOSE: Currently, the FDA allows biowaivers for Class I (high solubility and high permeability) and Class III (high solubility and low permeability) compounds of the Biopharmaceutics Classification System (BCS). Scientific evidence should be provided to support biowaivers for BCS Class I and Class...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Pharm Res
Huvudupphovsmän: Parr, Alan, Hidalgo, Ismael J., Bode, Chris, Brown, William, Yazdanian, Mehran, Gonzalez, Mario A., Sagawa, Kazuko, Miller, Kevin, Jiang, Wenlei, Stippler, Erika S.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Springer US 2015
Ämnen:
Research Paper
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4689772/
https://ncbi.nlm.nih.gov/pubmed/26286187
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11095-015-1773-4
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk